FDA Inspection 1205832 — LifeShare Blood Centers

LifeShare Blood Centers — FEI 2377737

The FDA completed an inspection of LifeShare Blood Centers on Apr 4, 2023 in Lake Charles, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 4, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lake Charles, LA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.